VAERS reports by lot

GSK Varicella/Shingles lot 57LJ9: VAERS reports

20 VAERS reports list lot 57LJ9 as a GSK Varicella/Shingles vaccine, received between 2021-09-19 and 2022-10-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1528%
Neurological1019%
Injection-site / Local reaction1019%
Musculoskeletal815%
Dermatological (non-injection-site)59%
Allergic / Anaphylactic36%
Cardiac / Cardiovascular12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
Illinois2
Michigan2
Alabama2
Florida1
Tennessee1
Ohio1
New Jersey1
South Carolina1
Virginia1
Indiana1
New York1

Reports by month received

2021-091
2021-102
2021-113
2021-126
2022-012
2022-023
2022-042
2022-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.